In Depth 27 Jul 2022
The race to uncloak cancer with liquid biopsies
Until recently, cancer detection depended on invasive solid tissue sampling that didn’t provide a complete picture. An emerging crowd of…
Qiagen
- Latest Posts
News and Trends 17 Apr 2018
How Low Can the Price of a Next Generation DNA Sequencer Go?
The next generation of DNA sequencers has arrived, and with it, a clash of titans: Illumina, Thermo Fisher and Qiagen…
News and Trends 1 Feb 2018
New Diagnostic Tests On the Way as Qiagen Snaps Up a Spanish Biotech
Qiagen will acquire Spanish biotech STAT-Dx for up to €153M - more than 3 times the total funding it has…
News and Trends 30 Nov 2017
Qiagen Joins French Biotech to Build the Next Generation of Microbiome Technology
Biomillenia harnesses the power of bacteria to keep the body healthy. The biotech has joined forces with Qiagen to develop…
ADVERTISEMENT
News and Trends 26 May 2016
Qiagen partners up for Novel Diagnostic against Breast Cancer
Qiagen is partnering up with Therawis to develop a diagnostic test to predict how effective an aggressive chemotherapy will be…
News and Trends 15 Apr 2016
Qiagen Deal to make Genetic Diagnostic Test for Lung Cancer
Qiagen and Mirati will collaborate on the development of a companion diagnostic for a specific type of form of Non-Small Lung Cancer -…
News and Trends 11 Jan 2016
How about the $100M Holy ‘GRAIL’ in Cancer Diagnostics? A Universal Test Start-up Faces German Competition
Illumina, the €22Bn Market cap NGS specialist, and Bill Gates pooled a $100M to fund the startup, 'Grail', which will…
News and Trends 24 Nov 2015
Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC
The World Leader in the Immuno-Oncology field has teamed up with a major German Investor to better identify breakthrough investment…
News and Trends 30 Jun 2015
Qiagen vs. Illumina, the next Big Fight in Next-gen Sequencing
Next-gen sequencing is a revolution. San Diego-based Illumina owns most of the market but German giant Qiagen is prepared to disrupt…
News and Trends 17 Jan 2015
Qiagen, the new giant in next-gen sequencing tools?
Yet again, a new acquisition in this beginning of 2015. Enzymatics, the Boston-area based Biotech company and leading provider of enzymes for…
News and Trends 27 Nov 2014
Curetis Raised Additional €14.5M to Diagnose Severe Infectious Diseases
Curetis AG, a developer of next-level molecular diagnostic solutions, has closed a EUR 14.5 million extension of its Series B financing round,…
